Page 30 - Biennial Report 2018-20 Jun 2021
P. 30

identified as Phaseolin and Phytoheameagglutinin. Currently, no treatment is available for food
                  allergy other than avoidance of offending allergen. However, immunotherapy with modified
                  offending allergen maybe useful as curative approach.
                  Using bioinformatics, cysteine protease was identified as a major allergen. showing more than
                  50% identity  with kiwifruit (Act d 1, Act  c 1), pollen (Amb a 11) and papaya (Car p 1) and
                  significant identity with mite and legume allergens. Recombinant cysteine protease showed 89%
                  sera reactivity in ELISA, indicating it to be a major allergen. Inhibition assay showed purified
                  protease as potent allergen upon self-inhibition. Cross-reactivity was observed maximally with
                  dust mite followed by peanut, black gram and fungal allergens. Cysteine protease was able to
                  activate passively sensitized basophils with upregulated expression of CD203c marker.

                  Four B-cell and T-cell epitopes were predicted using in-silico tools and further analysed for their
                  secondary structure and  other physicochemical properties. B-cell epitopes showed 52-95%
                  sequence conservation and T-cell showed 4-65% conservation among homologous allergen
                  sequences. MHC-class II coverage analysis of T-cell peptides showed about 80% coverage in
                  Indian population. A significant cross-reactivity of B-cell epitopes with known food allergens
                  shows potential of these epitopes in diagnostics. Further studies  will  be done with
                  immunotherapy with T cell epitopes.



                  ALLERGENIC FORMULATION FROM MUSHROOM Lentinula edodes


                  In a project aimed at development of selenium and vitamin D2 enriched formulation from a
                  mushroom,  Lentinula edodes  (Shiitake), Naveen Arora is involved in  in silico  allergenicity
                  assessment of the formulation, assessment and validation of allergenic potential of developed
                  formulations using in vitro assays followed by in vivo allergenicity assessment in mice.

                  Shiitake fungi (Lentinus edodes) is the second most commonly produced edible mushroom in the
                  world. It is commonly consumed by the eastern world. Many fungal species such as Coprinus
                  comatus, Psilocybe cubensis, and Boletus edulis etc. are allergenic. Studies have reported the
                  presence  of some allergenic proteins in  Lentinus edodes. One such study determined three
                  immunoreactive proteins of molecular weight 15 kDa, 24 kDa and 37 kDa. Immunoblotting with
                  patient serum showed two allergic bands at size 15 kDa and 24 KDa, which were exclusively
                  reactive to shiitake extract. The 37 kDa band showed less reactivity for the extract along with
                  some cross reactivity with the porcini  extract. Skin  prick test was performed  with in-house
                  mushroom extract and showed positive reaction. Another study described an atopic patient
                  allergic to Shiitake mushroom showing oesophageal symptoms. A positive skin prick test was
                  shown  with in house  made mushroom  extract. Both the basophil activation test and the
                  histamine release test were positive for the shiitake extract. Clinical symptoms and endoscopic
                  studies suggested the case of eosinophilic esophagitis.

                  At IGIB, an in silico screening of protein database (UniProt) for L. edodes’ proteins, obtained a
                  total of 12,608 hits. Out of these, only 287 protein sequences were shortlisted as they possessed
                  desired  molecular weight  (i.e. 15±1  kDa  and 24±1  kDa;  in  accordance to  prior  art).  Upon
                  subjecting to FASTA in Allergen Online database, only 131 proteins gave hits in either full FASTA
                  or 80 aa sliding window FASTA mode. Out of these, only 9 proteins gave plausible results (i.e. %
                  identity value above 50% for full FASTA and 35% for 80 aa sliding window FASTA). Two proteins


                                                           29
   25   26   27   28   29   30   31   32   33   34   35